Through the abstraction of genomic data from The Cancer Genome Atlas Breast Cancer (TCGA BRCA) tumor registry, we show that SPDEF downregulation serves as a negative prognostic indicator in breast cancer with varying significance across molecular and demographic subtypes. This evidence concerns the gene SPDEF and breast cancer.